Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigen

Clinical and Vaccine Immunology

Volumn 18, Issue 8, 2011, Pages 1292-1296

  Percival, Ann ^a   Thorkildson, Peter ^a   Kozel, Thomas R ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FUNGUS ANTIGEN; GLUCURONOXYLOMANNAN; MONOCLONAL ANTIBODY; POLYSACCHARIDE;

ANTIBODY SPECIFICITY; ANTIGEN CAPTURE SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; ANTIGEN DETECTION; ARTICLE; CARBOHYDRATE ANALYSIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DIAGNOSTIC VALUE; IMMUNOASSAY; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROTYPE;

ANTIBODIES, MONOCLONAL; ANTIGENS, FUNGAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; MYCOLOGICAL TYPING TECHNIQUES; POLYSACCHARIDES; SENSITIVITY AND SPECIFICITY; SEROTYPING;

EID: 79961118913     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05052-11     Document Type: Article

References (29)

1. Bacon, B. E., R. Cherniak, K. J. Kwon-Chung, and E. S. Jacobson. 1996. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy. Carbohydr. Res. 283:95-110. (Pubitemid 26092492)
2. Belay, T., and R. Cherniak. 1995. Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay. Infect. Immun. 63:1810-1819.
3. Belay, T., R. Cherniak, T. R. Kozel, and A. Casadevall. 1997. Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay. Infect. Immun. 65:718-728. (Pubitemid 27053245)
4. Bhattacharjee, A. K., J. E. Bennett, and C. P. J. Glaudemans. 1984. Capsular polysaccharides of Cryptococcus neoformans. Rev. Infect. Dis. 6:619-624.
5. Bloomfield, N., M. A. Gordon, and D. F. Elmendorf, Jr. 1963. Detection of Cryptococcus neoformans antigen in body fluids by latex particle agglutination. Proc. Soc. Exp. Biol. Med. 114:64-67.
6. Bottone, E. J., I. F. Salkin, N. J. Hurd, and G. P. Wormser. 1987. Serogroup distribution of Cryptococcus neoformans in patients with AIDS. J. Infect. Dis. 156:242.
7. Brandt, S., P. Thorkildson, and T. R. Kozel. 2003. Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans. Clin. Diagn. Lab Immunol. 10:903-909. (Pubitemid 37129507)
8. Cherniak, R., L. C. Morris, B. C. Anderson, and S. A. Meyer. 1991. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans. Infect. Immun. 59:59-64.
9. Cherniak, R., E. Reiss, M. E. Slodki, R. D. Plattner, and S. O. Blumer. 1980. Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans. Mol. Immunol. 17:1025-1032. (Pubitemid 10087383)
10. Cherniak, R., E. Reiss, and S. H. Turner. 1982. A galactoxylomannan antigen of Cryptococcus neoformans serotype A. Carbohydr. Res. 103:239-250.
11. Cherniak, R., H. Valafar, L. C. Morris, and F. Valafar. 1998. Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin. Diagn. Lab. Immunol. 5:146-159. (Pubitemid 28161182)
12. Eckert, T. F., and T. R. Kozel. 1987. Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide. Infect. Immun. 55:1895-1899.
13. Evans, E. E. 1950. The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular and agglutination reactions. J. Immunol. 64:423-430.
14. Evans, E. E. 1949. An immunologic comparison of twelve strains of Cryptococcus neoformans (Torula histolytica). Proc. Soc. Exp. Biol. Med. 71:644-646.
15. Ikeda, R., A. Nishikawa, T. Shinoda, and Y. Fukazawa. 1985. Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-D. Microbiol. Immunol. 29:981-991. (Pubitemid 16257513)
16. Karstaedt, A. S., H. H. Crewe-Brown, and F. Dromer. 2002. Cryptococcal meningitis caused by Cryptococcus neoformans var. gattii, serotype C, in AIDS patients in Soweto, South Africa. Med. Mycol. 40:7-11. (Pubitemid 34168302)
17. Kozel, T. R. 1989. Antigenic structure of Cryptococcus neoformans capsular polysaccharides, p. 63-86. In E. Kurstak and G. Marquis (ed.), Immunology of fungal diseases. Marcel Dekker, Inc., New York, NY.
18. Kozel, T. R., and E. C. Gotschlich. 1982. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J. Immunol. 129:1675-1680. (Pubitemid 12031112)
19. Kozel, T. R., et al. 2003. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. Infect. Immun. 71:2868-2875. (Pubitemid 36519900)
20. Litvintseva, A. P., R. Thakur, L. B. Reller, and T. G. Mitchell. 2005. Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in sub-Saharan Africa. J. Infect. Dis. 192:888-892. (Pubitemid 41193087)
21. Peterman, J. H. 1991. Immunochemical considerations in the analysis of data from non-competitive solid-phase immunoassays, p. 47-65. In J. E. Butler (ed.), Immunochemistry of solid-phase immunoassay. CRC Press, Inc., Boca Raton, FL.
22. Peterman, J. H., and J. E. Butler. 1989. Application of theoretical considerations to the analysis of ELISA data. Biotechniques 7:608-615. (Pubitemid 19180070)
23. Rinaldi, M. G., et al. 1986. Serotypes of Cryptococcus neoformans in patients with AIDS. J. Infect. Dis. 153:642.
24. Shimizu, R. Y., D. H. Howard, and M. N. Clancy. 1986. The variety of Cryptococcus neoformans in patients with AIDS. J. Infect. Dis. 154:1042.
25. Spiropulu, C., R. A. Eppard, E. Otteson, and T. R. Kozel. 1989. Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide. Infect. Immun. 57: 3240-3242. (Pubitemid 19240102)
26. Swinne, D., J. B. Nkurikiyinfura, and T. L. Muyembe. 1986. Clinical isolates of Cryptococcus neoformans from Zaire. Eur. J. Clin. Microbiol. 5:50-51. (Pubitemid 16129282)
27. Thakur, R., et al. 2009. Prevalence of C. neoformans and C. gattii among patients with cryptococcal meningitis at a tertiary hospital in Gaborone, Botswana: March 2005-February 2007, abstr. 1048. Abstr. 47th Annu. Meet. IDSA, Philadelphia, PA.
28. Turner, S. H., and R. Cherniak. 1991. Multiplicity in the structure of the glucuronoxylomannan of Cryptococcus neoformans, p. 123-142. In J. P. Latgé and D. Boucias (ed.), Fungal cell wall and immune response. Springer- Verlag, Berlin, Germany.
29. Wilson, D. E., J. E. Bennett, and J. W. Bailey. 1968. Serologic grouping of Cryptococcus neoformans. Proc. Soc. Exp. Biol. Med. 127:820-823.